• 1. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 2. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 4. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives

1-(5-Fluoropyridin-2-yl)cyclopropane-1-carbonitrile (CAS No. 1302580-97-7)

The compound 1-(5-fluoropyridin-2-yl)cyclopropane-1-carbonitrile, identified by the CAS number 1302580-97-7, is a highly specialized organic molecule with significant potential in various chemical and pharmaceutical applications. This compound has garnered attention in recent years due to its unique structural properties and promising biological activities. The molecule consists of a cyclopropane ring fused with a pyridine ring, substituted with a fluorine atom at the 5-position and a cyano group at the 2-position of the pyridine ring. This configuration imparts distinctive electronic and steric properties, making it a valuable substrate for further chemical modifications and functionalization.

Recent studies have highlighted the importance of cyclopropane-containing compounds in drug discovery, particularly in the development of novel therapeutic agents. The cyclopropane ring introduces strain and rigidity into the molecule, which can enhance binding affinity to specific biological targets. For instance, researchers have explored the use of 1-(5-fluoropyridin-2-yl)cyclopropane-1-carbonitrile as a potential lead compound in anti-cancer drug development. The fluorine substitution at the 5-position of the pyridine ring enhances lipophilicity, which is crucial for improving drug bioavailability and permeability across biological membranes.

In addition to its pharmacological applications, this compound has also been investigated for its role in advanced materials science. The cyano group attached to the cyclopropane ring can participate in various types of non-covalent interactions, such as hydrogen bonding and π-interactions, which are essential for constructing supramolecular assemblies. These assemblies have potential applications in nanotechnology, including the development of self-healing materials and stimuli-responsive systems.

The synthesis of 1-(5-fluoropyridin-2-yl)cyclopropane-1-carbonitrile involves a multi-step process that combines principles from organic synthesis and catalytic chemistry. Key steps include the formation of the pyridine ring via cyclization reactions, followed by fluorination at the 5-position using electrophilic fluorination techniques. The introduction of the cyclopropane ring and cyano group requires precise control over reaction conditions to ensure high yields and selectivity. Recent advancements in transition metal-catalyzed cycloaddition reactions have significantly improved the efficiency of these processes, making large-scale production more feasible.

The biological evaluation of this compound has revealed intriguing results. In vitro studies have demonstrated its ability to inhibit specific kinases involved in cellular signaling pathways associated with cancer progression. Furthermore, preliminary toxicity studies indicate that 1-(5-fluoropyridin-2-yl)cyclopropane-1-carbonitrile exhibits low cytotoxicity against normal human cells, suggesting a favorable therapeutic index. These findings underscore its potential as a lead compound for developing targeted therapies with reduced side effects.

In conclusion, 1-(5-fluoropyridin-2-yl)cyclopropane-1-carbonitrile (CAS No. 1302580-97-) represents a promising molecule with diverse applications across multiple scientific domains. Its unique structure, combined with recent advancements in synthetic methodologies and biological evaluations, positions it as a valuable asset in both academic research and industrial development. As ongoing studies continue to unravel its full potential, this compound is expected to play a pivotal role in shaping future innovations in chemistry and pharmacology.

• 960371-08-8(2-(5-fluoro-2-pyridyl)acetonitrile)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)